Minerva Surgical Inc Receivables Turnover Ratio (UTRS), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Minerva Surgical Inc   (NASDAQ: UTRS)
 

Minerva Surgical Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Minerva Surgical Inc 's ability to collect accounts receivable sequentially worsen to 6.63, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Minerva Surgical Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 55 days, from 52 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 265 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 1946 to 2085.

What is Receivable Turnover Ratio?
What is Minerva Surgical Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UTRS Receivables Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Receivable Change 11.46 % 13.23 % 3.38 % -0.66 % 0.49 %
Y / Y Revenue Change -10.88 % -4.36 % 14.61 % 1.17 % 0.66 %
Receivable Turnover Ratio (TTM) 6.63 6.99 7.3 7.13 7.1
UTRS's Total Ranking # 2085 # 1946 # 2084 # 1680 # 1680
Accounts Receivable average collection period days 55 52 50 51 51
Seq. Receivable Change -4.73 % 7.48 % 2.04 % 6.67 % -3.22 %
Seq. Revenue Change -9.55 % -1.05 % -9.21 % 9.66 % -2.92 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 85
Healthcare Sector # 266
Overall Market # 2085

Receivable Turnover Ratio Statistics
High Average Low
7.4 6.03 3.39
(Sep 30 2021)   (Jun 30 2022)





UTRS Company Profile • Back to UTRS Efficiency Comparisons • Compare UTRS Receivables Turnover Ratio to its Competitors

Financial Statements
Minerva Surgical Inc 's Accounts Receivable $ 8 Millions Visit UTRS's Balance sheet
Minerva Surgical Inc 's Sales TTM $ 50 Millions Visit UTRS's Income Statement
Sources of UTRS's Revenues Visit UTRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
UTRS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
UTRS's Growth Rates UTRS's Roa UTRS's Inventory Turnover Ratio UTRS's Dividend Comparisons
UTRS's Profitability Ratios UTRS's Roi UTRS's Asset Turnover Ratio UTRS's Dividend Growth
UTRS's Valuation Ratios UTRS's Roe UTRS's Financial Strength Ratios UTRS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Qhslab Inc   17.62 $ 1.362  Millions$ 0.077  Millions
Arvinas Inc   17.55 $ 167.200  Millions$ 9.525  Millions
Recursion Pharmaceuticals Inc   17.18 $ 47.360  Millions$ 2.756  Millions
Opus Genetics Inc   15.89 $ 57.208  Millions$ 3.600  Millions
Lftd Partners Inc   15.79 $ 49.404  Millions$ 3.129  Millions
Chemed Corporation  15.30 $ 2,225.159  Millions$ 145.392  Millions
Vystar Corporation  15.28 $ 0.417  Millions$ 0.027  Millions
Patterson Companies Inc   14.56 $ 6,550.083  Millions$ 449.864  Millions
Talkspace Inc   14.24 $ 137.071  Millions$ 9.623  Millions
Ainos Inc   14.15 $ 1.140  Millions$ 0.081  Millions
Comera Life Sciences Holdings Inc   14.07 $ 1.000  Millions$ 0.071  Millions
Lifeloc Technologies Inc   14.00 $ 9.250  Millions$ 0.661  Millions
Nexalin Technology Inc   13.80 $ 0.129  Millions$ 0.009  Millions
Corcept Therapeutics Inc  13.76 $ 450.026  Millions$ 32.698  Millions
Protalix Biotherapeutics inc   13.48 $ 63.625  Millions$ 4.719  Millions
Exact Sciences Corporation  13.42 $ 2,413.259  Millions$ 179.784  Millions
Arrowhead Pharmaceuticals Inc   13.36 $ 240.735  Millions$ 18.023  Millions
Petvivo Holdings Inc   13.14 $ 0.960  Millions$ 0.073  Millions
Icu Medical Inc  13.12 $ 2,247.910  Millions$ 171.300  Millions
Milestone Scientific Inc   13.11 $ 9.788  Millions$ 0.747  Millions
Dmk Pharmaceuticals Corporation  12.53 $ 3.525  Millions$ 0.281  Millions
Utah Medical Products Inc  12.49 $ 51.339  Millions$ 4.112  Millions
Ideaya Biosciences Inc   12.46 $ 23.484  Millions$ 1.886  Millions
Nutriband Inc   12.45 $ 2.088  Millions$ 0.168  Millions
Precipio inc   12.45 $ 13.259  Millions$ 1.065  Millions
Revance Therapeutics Inc   12.38 $ 214.162  Millions$ 17.292  Millions
Equillium Inc   12.38 $ 42.632  Millions$ 3.444  Millions
Amylyx Pharmaceuticals Inc   12.30 $ 294.222  Millions$ 23.922  Millions
Caribou Biosciences Inc   12.19 $ 34.611  Millions$ 2.840  Millions
Strata Critical Medical Inc   12.18 $ 215.837  Millions$ 17.726  Millions

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.